Sciresol Sciresol https://ijpccr.com/# International Journal of Preclinical & Clinical Research XXXX-XXXX 10.51131/IJPCCR/v2i2.16 Research Article A study on serum uric acid levels and insulin resistance in type-2 diabetic subjects Thweja N 1 Divya D drdivyad09@gmail.com 2 Vickram 3 Post graduate, Kannur University Kerala Associate Professor, Department of Biochemistry, Basaveshwara Medical College and Hospital Chitradurga, Karnataka, 577502 India Professor, Department of Biochemistry, Basaveshwara Medical College and Hospital Chitradurga, Karnataka, 577502 India 2 2 38 2021 Abstract

Insulin resistance (IR) is the principle etiological factor for development and progression of type-2 diabetes mellitus (T2DM) and decreased insulin function. Independently, increased serum uric acid (SUA) is known to play a critical role in the development of T2DM as well as in progression of its complications. To assess the correlation between SUA levels and IR in diabetic patients, data with lab investigations of HbA1c, fasting levels of serum glucose, UA, TAG, HDL-C of confirmed and known cases of T2DM were collected from the Hospital Biochemistry Laboratory, DMWIMS Hospital, Wayanad, Kerala. Fasting ratio of TAG to HDL-C was used as an index for IR. A significant increase in fasting serum glucose, SUA, HBA1C, TAG, TAG/HDL-C ratio (IR) and a significant decrease in HDL-C were observed in data of cases when compared with the data of normal healthy subjects. This study shows a positive correlation between SUA levels and IR in known cases of T2DM.

 Keywords ­ type­2 diabetes mellitus serum uric acid insulin resistance None Introduction

Insulin resistance (IR) is the principle etiological factor for development and progression of type-2 diabetes mellitus (T2DM) and decreased insulin function. Independently, increased serum uric acid (SUA) is known to play a critical role in the development of T2DM as well as in progression of its complications 1. However, hyperuricemia is not always found in diabetic individuals. Conflicting data exist about UA levels in T2DM, as low levels were found in diabetic patients, while elevated SUA is a feature of hyperinsulinemia and impaired glucose tolerance 2. The present study was undertaken to assess the correlation between SUA levels and IR in known cases of T2DM.

 Materials and Methods <bold id="strong-d75a1520735941068291da934f6a05fa">Study Setting & Data Source</bold>

A retrospective observational case control study was conducted in DM WIMS Hospital, Wayanad, Kerala, in collaboration with Department of Medical Biochemistry, School of Health Sciences, Palayad, Kannur University, Kerala, during the period from May 2019 to July 2019. Institutional Research Committee approval has been taken for conducting this study. A year data (from Jan 2018-Jan 2019) of confirmed and known cases of T2DM were collected along with the normal subjects’ data, from the Hospital Biochemistry Laboratory.

<bold id="strong-1">Study Subjects & Groups</bold>

The present study included data of total of 107 subjects out of whom 52 were of healthy normal individuals and 55 were of known cases of T2DM and were grouped as Group-1 and Group-2 respectively. The normal subjects had a mean age of 43.13 ± 5.98 years of which 23 were males and 29 were female and diabetic subjects had mean age of 61.06 ± 13.19 years of which 31 were males and 24 were females. Inclusion criteria: Both male and female patients >35 years of age with known case of T2DM were included in this study. Exclusion criteria: Patients with Type-1 DM, patients with acute complications of DM, those with a history of acute infections and other ailments like gross congestive heart failure, tuberculosis, gout, rheumatoid arthritis and skeletal muscle injury, those with serum creatinine levels of >1.5 mg/dl, renal failure, diabetic nephropathy, uric acid lowering drugs, were excluded from the study.

 <bold id="strong-328963eb9f4e4ac9a983bf3680746a18">Study Parameters</bold> <bold id="strong-7641ca9c1ee7407487108efad68d1689"> </bold>

Data of fasting serum levels of glucose (FBS), uric acid (UA), Triacylglycerol (TAG), High density lipoprotein- Cholesterol (HDL-C) and Glycated Hb (HbA1c), of both type-2 diabetic and normal subjects were assessed for the present study. Estimation principles of the studied parameters were as follows: Glucose by hexokinase method 3, 4, HbA1c by HPLC method 5 TAG by enzymatic colorimetric test 6, HDL-C by homogenous enzymatic colorimetric assay 7, 8, UA by enzymatic colorimetric test 9, 10. Data of serum TAG and serum HDL-C were used to calculate IR. There are many limitations to establish direct methods for measuring insulin resistance in vivo. So, an indirect method is used for calculating IR index. TAG to HDL-C ratio is the indirect method 11, 12, 13, that has been reported to be closely related to IR in adults. All the parameters were estimated using Roche Cobas Integra 400 -Plus fully automated analyzer.

 <bold id="strong-69ae32a526f14e68a339a0017325741c">Statistical Evaluation</bold>

Data analysis was done using SPSS software version 24 (IBM, Armonk, NY, USA). The data were expressed as their Mean ± SD and the statistical significance was calculated using Mann Whitney U test. p < 0.05 was considered as significant and p < 0.001 was considered to be statistically highly significant. Pearson correlation ‘r’ was used to assess the correlation between serum uric acid levels and insulin resistance

 Results

The results of the present study are depicted in Table 1 and Figure 1.

Showing fasting levels of serum glucose, SUA, HbA1c, serum TAG, serum HDL-C & IR as ratio of TAG/HDL-C, in both Group-1 & Group-2 subjects

Parameters

FBS mg/dL

HbA1C %

SUA mg/dL

TAG mg/dL

HDL-C mg/dL

IR [TAG/HDL-C ratio]

Group-1 (52)

87.15±6.94

5.01±0.36

4.63±1.14

99.32±22.95

47.18±11.66

2.22±0.66

Group-2 (55)

198.34±65.79

9.50±2.04

8.30±1.30

213.05±47.19

40.07±9.79

5.47±1.47

P value

< 0.001

< 0.001

< 0.001

< 0.001

< 0.002

< 0.001

Figure 1: Showing Pearson’s correlation co-efficient for the correlation between SUA levels and TG/HDL -C ratio (IR) among Group-2 subjects

Pearson's correlation co-efficent r=0.6 Insulin resistance (IR) was indirectly calculated as TAG/HDL-C ratio Discussion

The association of hyperuricemia and development of T2DM have been observed by various researchers 1, 14. Many studies have also shown that elevated levels of SUA may lead to progression of chronic complications such as CVD and CKD in diabetic patients 15, 16, 17. Hyperuricemia & hypertriglyceridemia are suggested to be associated with insulin resistance syndrome 18, 19, 20.

The results of the present study show a positive correlation (r = 0.605) between SUA & IR (calculated indirectly by measuring the ratio of TAG/HDL-C) [refer Table 1 & Figure 1]. This is consistent with the recent meta-analysis by Xu et al 21. The mechanism for uric acid-induced insulin resistance appears to be mediated by the development of mitochondrial oxidative stress and impairment of insulin-dependent stimulation of nitric oxide in endothelial cells, mediated by the expression of CRP 22. Pilot studies in humans have reported a potential benefit of lowering SUA on IR 23.

Limitations of the study

This study may come short of generalizability and authenticity due to small sample size, not analyzing sufficient dependent and independent variables, and fails to account for any confounders effect.

 Conclusion

The present study shows a positive correlation between SUA and IR in type-2 diabetic patients suggesting that SUA may serves as a better risk indicator of IR status. Lowering SUA may prove to be a simple and inexpensive strategy to help prevent the development of diabetes and/or its complications and to slow down the epidemic. Large clinical trials with SUA lowering drugs are recommended. 

 References Kodama S. Saito K. Yachi Y. Asumi M. Sugawara A. Totsuka K. Association Between Serum Uric Acid and Development of Type 2 Diabetes Diabetes Care 2009 32 9 1737 1742 0149-5992, 1935-5548 American Diabetes Association https://dx.doi.org/10.2337/dc09-0288 Čaušević Adlija Semiz Sabina Macić-Džanković Amra Cico Bakira Dujić Tanja Malenica Maja Relevance of uric Acid in progression of type 2 diabetes mellitus Bosn J Basic Med Sci 2010 10 1 54 59 https://doi.org/10.17305/bjbms.2010.2736 Neeley William E Simple Automated Determination of Serum or Plasma Glucose by a Hexokinase/Glucose-6-Phosphate Dehydrogenase Method Clinical Chemistry 1972 18 6 509 515 0009-9147, 1530-8561 Oxford University Press (OUP) https://dx.doi.org/10.1093/clinchem/18.6.509 Bondar R J Mead D C Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum Clin Chem 1974 20 5 586 590 Mayer T K Freedman Z R Protein glycosylation in diabetes mellitus: a review of laboratory measurements and of their clinical utility Clin Chim Acta 1983 127 2 147 184 10.1016/s0009-8981(83)80002-3 Siedel J Schmuck R Staepels J Town M H Long term stable, liquid ready to use monoreagent for the enzymatic assay of serum or plasma triglycerides (GPO-PAP method). AACC Meeting Abstract 34 Clin Chem 1993 39 1127 Sugiuchi H Uji Y Okabe H Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin Clin Chem 1995 41 5 717 723 Matsuzaki Y Kawaguchi E Morita Y Mashige F Ohisa S Nakahara K Evaluation of two kinds of reagents for direct determination of HDL-cholesterol J Anal Bio-Sc 1996 19 419 446 Kageyama Nobuo A direct colorimetric determination of uric acid in serum and urine with uricase-catalase system Clinica Chimica Acta 1971 31 2 421 426 0009-8981 Elsevier BV https://dx.doi.org/10.1016/0009-8981(71)90413-x Digiorgio J Henry R J Clinical chemistry: Principles and Technics 84 Harper and Row 1972 217 Li Chaoyang Ford Earl S Meng Yuan-Xiang Mokdad Ali H Reaven Gerald M Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovascular Diabetology 2008 7 1 4 1475-2840 Springer Science and Business Media LLC https://dx.doi.org/10.1186/1475-2840-7-4 Snehalatha C Satyavani K Sivasankari S Vijay V Ramachandran A Serum triglycerides as a marker of insulin resistance in non-diabetic urban Indians Diabetes Res Clin Pract 2005 69 2 205 206 10.1016/j.diabres.2005.03.021 Bovet Pascal Faeh David Gabriel Anne Tappy Luc The Prediction of Insulin Resistance With Serum Triglyceride and High-Density Lipoprotein Cholesterol Levels in an East African Population Archives of Internal Medicine 2006 166 11 1236 1237 0003-9926 American Medical Association (AMA) https://dx.doi.org/10.1001/archinte.166.11.1236-b Wu Y T He H Wang X Zhang M An Z M Huang H J Serum Uric Acid and Islet β-cell Function in Patients with Pre-diabetes and Type 2 Diabetes Mellitus Sichuan Da Xue Xue Bao Yi Xue Ban 2018 49 1 69 73 https://pubmed.ncbi.nlm.nih.gov/29737093/ Zoppini G. Targher G. Chonchol M. Ortalda V. Abaterusso C. Pichiri I. Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function Diabetes Care 2012 35 1 99 104 0149-5992, 1935-5548 American Diabetes Association https://dx.doi.org/10.2337/dc11-1346 Culleton B F Larson M G Kannel W B Levy D Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study Ann Intern Med 1999 131 1 7 13 10.7326/0003-4819-131-1-199907060-00003 Mazzali Marilda Hughes Jeremy Kim Yoon-Goo Jefferson J. Ashley Kang Duk-Hee Gordon Katherine L. Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism Hypertension 2001 38 5 1101 1106 0194-911X, 1524-4563 10.1161/hy1101.092839 Ovid Technologies (Wolters Kluwer Health) https://dx.doi.org/10.1161/hy1101.092839 Yoo T W Sung K C Shin H S Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome Circ J 2005 69 8 928 933 10.1253/circj.69.928 Vuorinen-Markkola H Yki-Järvinen H Hyperuricemia and insulin resistance J Clin Endocrinol Metab 1994 78 1 25 29 10.1210/jcem.78.1.8288709 Cigolini M Targher G Tonoli M Manara F Muggeo M Sandre De G Hyperuricaemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women Int J Obes Relat Metab Disord 1995 19 2 92 96 Yi-LiXu Kuan-FengXu Jian-LingBai YunLiu Rong-BinYu Chun-LanLiu Elevation of serum uric acid and incidence of type 2 diabetes: A systematic review and meta-analysis Chronic Dis Transl Med 2016 2 2 81 91 https://doi.org/10.1016/j.cdtm.2016.09.003 Kang D H Park S K Lee I K Johnson R J Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells J Am Soc Nephrol 2005 16 12 3553 3562 10.1681/ASN.2005050572 King C Lanaspa M A Jensen T Tolan D R Sánchez-Lozada L G Johnson R J Uric Acid as a Cause of the Metabolic Syndrome Contrib Nephrol 2018 192 88 102 10.1159/000484283